Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia

被引:8
作者
Koh, Joon [1 ]
Kurago, Zoya B. [1 ,2 ]
机构
[1] Augusta Univ, Dent Coll Georgia, GC2250 1430 JW Gilbert Dr, Augusta, GA 30912 USA
[2] Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, Augusta, GA 30912 USA
关键词
Proliferative verrucous leukoplakia; PVL; Verrucous hyperplasia; Toll-like receptor 2; TLR2; Squamous epithelium; Squamous cell carcinoma; Oral cancer; CANCER; LIPOPOLYSACCHARIDE; RECOGNITION;
D O I
10.1007/s12105-019-01028-y
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Proliferative verrucous leukoplakia (PVL) is a premalignant condition of the oral mucosa with > 70% chance of progression to squamous cell carcinoma (SCC), while lacking the common risks and behavior seen in non-PVL oral squamous carcinogenesis. PVL follows a multi-stage slow, relentless and usually multifocal expansion of surface epithelial thickening that over time takes on a verrucous architecture, eventually leading to verrucous carcinoma and/or dysplasia followed by "conventional" SCC, a process that takes years and is notoriously difficult to manage. As mucosal surfaces and carcinomas arising at these sites, are colonized by microorganisms, host receptors for microbial products have received attention as potential contributors to carcinogenesis. Studies show that microbial pattern recognition toll-like receptor (TLR)2 in various epithelial cells is upregulated in premalignant lesions and in malignant cells and can activate oncogenic pathways. Because of the highly progressive nature of PVL, we examined TLR2 expression in well-characterized PVL samples by immunohistochemistry. We found that, similar to epithelial dysplasia and SCC, PVL keratinocytes throughout the epithelial thickness showed diffuse TLR2 expression even in early stage lesions prior to onset of dysplasia. In contrast, oral mucosal samples in the absence of hyperorothokeratosis or dysplasia, expressed TLR2 primarily in the basal and parabasal layers. Given the high rates of PVL transformation and the previously established pro-cancer role of high TLR2 expression in malignant oral squamous cells, it is important to determine how its' expression and functions are regulated in the oral squamous epithelium, and what is the specific TLR2 role in carcinogenesis.
引用
收藏
页码:635 / 642
页数:8
相关论文
共 33 条
  • [1] [Anonymous], 2017, WHO CLASSIFICATION H
  • [2] Oral Pathobiont Activates Anti-Apoptotic Pathway, Promoting both Immune Suppression and Oncogenic Cell Proliferation
    Arjunan, Pachiappan
    Meghil, Mohamed M.
    Pi, Wenhu
    Xu, Jinxian
    Lang, Liwei
    El-Awady, Ahmed
    Sullivan, William
    Rajendran, Mythilypriya
    Rabelo, Mariana Sousa
    Wang, Tong
    Tawfik, Omnia K.
    Kunde-Ramamoorthy, Govindarajan
    Singh, Nagendra
    Muthusamy, Thangaraju
    Susin, Cristiano
    Teng, Yong
    Arce, Roger M.
    Cutler, Christopher W.
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [3] Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment
    Atretkhany, K. -S. N.
    Drutskaya, M. S.
    Nedospasov, S. A.
    Grivennikov, S. I.
    Kuprash, D. V.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2016, 168 : 98 - 112
  • [4] The role of tight junctions in skin barrier function and dermal absorption
    Baesler, Katja
    Bergmann, Sophia
    Heisig, Michael
    Naegel, Arne
    Zorn-Kruppa, Michaela
    Brandner, Johanna M.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2016, 242 : 105 - 118
  • [5] Beasley NJP, 2002, CANCER RES, V62, P2493
  • [6] HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
    Castellsague, Xavier
    Alemany, Laia
    Quer, Miquel
    Halec, Gordana
    Quiros, Beatriz
    Tous, Sara
    Clavero, Omar
    Alos, Llucia
    Biegner, Thorsten
    Szafarowski, Tomasz
    Alejo, Maria
    Holzinger, Dana
    Cadena, Enrique
    Claros, Edith
    Hall, Gillian
    Laco, Jan
    Poljak, Mario
    Benevolo, Maria
    Kasamatsu, Elena
    Mehanna, Hisham
    Ndiaye, Cathy
    Guimera, Nuria
    Lloveras, Belen
    Leon, Xavier
    Ruiz-Cabezas, Juan C.
    Alvarado-Cabrero, Isabel
    Kang, Chang-Suk
    Oh, Jin-Kyoung
    Garcia-Rojo, Marcial
    Iljazovic, Ermina
    Ajayi, Oluseyi F.
    Duarte, Flora
    Nessa, Ashrafun
    Tinoco, Leopoldo
    Duran-Padilla, Marco A.
    Pirog, Edyta C.
    Viarheichyk, Halina
    Morales, Hesler
    Costes, Valerie
    Felix, Ana
    Germar, Maria Julieta V.
    Mena, Marisa
    Ruacan, Arzu
    Jain, Asha
    Mehrotra, Ravi
    Goodman, Marc T.
    Lombardi, Luis Estuardo
    Ferrera, Annabelle
    Malami, Sani
    Albanesi, Estela I.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (06):
  • [7] TLR2 activation induced by H. pylori LPS promotes the differential expression of claudin-4,-6,-7 and-9 via either STAT3 and ERK1/2 in AGS cells
    Chavarria-Velazquez, Christian O.
    Torres-Martinez, Ana C.
    Montano, Luis F.
    Rendon-Huerta, Erika P.
    [J]. IMMUNOBIOLOGY, 2017, 223 (01) : 38 - 48
  • [8] TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence
    Chefetz, Ilana
    Alvero, Ayesha B.
    Holmberg, Jennie C.
    Lebowitz, Noah
    Craveiro, Vinicius
    Yang-Hartwich, Yang
    Yin, Gang
    Squillace, Lisa
    Soteras, Marta Gurrea
    Aldo, Paulomi
    Mor, Gil
    [J]. CELL CYCLE, 2013, 12 (03) : 511 - 521
  • [9] Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
    Dajon, Marion
    Iribarren, Kristina
    Cremer, Isabelle
    [J]. IMMUNOBIOLOGY, 2017, 222 (01) : 89 - 100
  • [10] Toll-like receptors: Activation, signalling and transcriptional modulation
    De Nardo, Dominic
    [J]. CYTOKINE, 2015, 74 (02) : 181 - 189